BIOMAT Database Logo BIOMAT Database Logo

Cytotoxic antibody reactivity in sera of melanoma patients against allogeneic and autologous cultured tumor cells and fibroblasts. 1982

J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor
D000920 Antibody-Dependent Cell Cytotoxicity The phenomenon of antibody-mediated target cell destruction by non-sensitized effector cells. The identity of the target cell varies, but it must possess surface IMMUNOGLOBULIN G whose Fc portion is intact. The effector cell is a "killer" cell possessing Fc receptors. It may be a lymphocyte lacking conventional B- or T-cell markers, or a monocyte, macrophage, or polynuclear leukocyte, depending on the identity of the target cell. The reaction is complement-independent. ADCC,Cytotoxicity, Antibody-Dependent Cell,Cell Cytoxicity, Antibody-Dependent,Antibody Dependent Cell Cytotoxicity,Antibody-Dependent Cell Cytotoxicities,Antibody-Dependent Cell Cytoxicities,Antibody-Dependent Cell Cytoxicity,Cell Cytotoxicities, Antibody-Dependent,Cell Cytotoxicity, Antibody-Dependent,Cell Cytoxicities, Antibody-Dependent,Cell Cytoxicity, Antibody Dependent,Cytotoxicities, Antibody-Dependent Cell,Cytotoxicity, Antibody Dependent Cell,Cytoxicities, Antibody-Dependent Cell,Cytoxicity, Antibody-Dependent Cell

Related Publications

J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg
Immunofluorescent detection of common melanoma membrane antigens by sera of melanoma patients immunized against autologous or allogeneic cultured melanoma cells.
November 1977, Cancer research,
J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg
Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.
May 1977, Journal of the National Cancer Institute,
J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg
Absence of melanoma specificity in the reactivity of melanoma patients' sera with cultured allogeneic melanoma cell lines.
May 1982, Cancer,
J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg
Antibody binding to membrane of cultured melanoma cells by sera of melanoma patients.
February 1979, Tumori,
J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg
Levels of cytotoxic reactivity to cultured normal skin fibroblasts in sera from normal and sarcoma-bearing patients.
April 1980, Cancer research,
J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg
Cytotoxic activity of lymphocytes and sera from New Zealand mice against allogeneic fibroblasts.
November 1973, The Tohoku journal of experimental medicine,
J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg
Autologous, allogeneic tumor cells or genetically engineered cells as cancer vaccine against melanoma.
September 2000, Immunology letters,
J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg
Generation of autologous tumor-specific cytotoxic T-cells using HLA-A region matched allogeneic melanoma.
January 1989, Current surgery,
J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg
Specific cytotoxic antibody in the sera of patients with melanoma.
November 1976, The Journal of surgical research,
J M Brown, and P C Shoffner, and S P Tondreau, and E J Matthews, and W D Terry, and S A Rosenberg
Serological response of melanoma patients to vaccines prepared from VSV lysates of autologous and allogeneic cultured melanoma cells.
February 1985, Cancer,
Copied contents to your clipboard!